Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
about
Epigenetic modifications and diabetic retinopathyOxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyPosttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon.Developments in Ocular Genetics: 2013 Annual ReviewSirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia.Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyEmerging roles of the myocardin family of proteins in lipid and glucose metabolism.Diabetes and retinal vascular dysfunction.Epigenetic mechanisms in diabetic complications and metabolic memory.Posttranslational modification of Sirt6 activity by peroxynitrite.Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy.Epigenetic Mechanisms of the Aging Human Retina.Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathwayTranscription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathyDynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathyThe Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.Abnormal levels of histone methylation in the retinas of diabetic rats are reversed by minocycline treatment.Epigenetics in extracellular matrix remodeling and hyaluronan metabolism.Epigenetic modifications and potential new treatment targets in diabetic retinopathyDiabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?Contribution of epigenetics in diabetic retinopathy.The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytesMetalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiologyDiabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets.Solar-simulated ultraviolet radiation induces histone 3 methylation changes in the gene promoters of matrix metalloproteinases 1 and 3 in primary human dermal fibroblasts.Apoptotic effect of mtrix metalloproteinases 9 in the development of diabetic retinopathy.Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.Sirt1- A Guardian of the Development of Diabetic Retinopathy.Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.The genetics of retinopathy of prematurity: a model for neovascular retinal diseaseEpigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy
P2860
Q21284810-E7147B7D-AF9F-4E90-B79E-77B1B07B36D5Q29248994-851A2E43-A9A5-4613-A1AC-7D79D6815228Q33676124-DD3DB47F-5146-4257-A9FE-E50C6E54604DQ33991982-FFDBB01C-ACE0-45D4-B553-A1C7767E120FQ34159652-5C80C8C1-ADB2-4A8C-B9C6-F28852157911Q34433611-4CCFBB09-D98B-46D7-9D75-9AC1CFB3BF49Q34511162-A4F0ABEF-F581-4125-B25E-16DEF2525FE9Q34521411-E6E1414B-F283-4553-94F6-F16AFE24965DQ35017752-880A9882-8AC7-4EC9-A680-B0A5605F873CQ35071700-6012DB90-2329-4838-B12F-D282B46CD1C5Q35118010-4F1EBAFF-D275-4FD3-888D-0C40D570A415Q35790594-0B4119C2-ED43-47E5-AE35-6A7989DAAD41Q36648831-FEC46294-EC6D-46B9-B343-596C9526FAA2Q36719371-91E6067B-6BC0-47F2-8779-1367067805CAQ36911967-AC7ECC77-4F65-421A-B7B2-23718B84548AQ37280210-38D2C293-8F90-4DF7-AA2C-1D72D1EA8595Q37384357-5E9EA3A4-0FDC-48BD-9D80-A5547DF7DACAQ37396370-BD3E6B9B-AE9D-4964-BF95-D39671DA31A5Q37719402-93A3012C-3D93-491F-A194-B6AB372212BFQ38231435-FE23EDA4-7884-49AC-833D-6C4594A22996Q38244141-5CD518EE-DF82-48B2-ABE7-E5A13A77A38FQ38365800-7DDFE515-110B-47DF-B3D0-7A318845E41BQ38508141-F00953E1-A041-4D20-ADF2-01C97EB283B2Q38710512-47C98792-677B-4837-BFD6-802657778F8CQ38902929-7DE7FEB4-ED1D-4C22-A761-145263FA8BE8Q39052777-2B92ACF5-EEE5-4A83-AD81-E6C2A4294382Q40796520-043F02EB-6D11-431B-B0AA-7FD2525A7E76Q41374334-14E376A0-A34B-49F9-908D-6BC7E5B096CDQ41413793-976C0DD8-32C5-467F-BC29-C46898B7F8C1Q41848436-420083E9-F25F-4A4B-BE70-A1841E827DF6Q42107211-C89A5387-36E7-4F13-ACF3-DC8A069EDC36Q47122605-9B38C0E8-A6E8-44C8-BFFF-D8015E57C666Q50049076-50FD78E9-12D4-4F85-9EA1-D14E607A53D7Q50133670-A91AB332-2B2D-4DD9-BCC3-E1650B589FB0Q50931649-A34E3C61-B5BB-4A5E-A107-5511154512C4Q51016986-895A97B4-AB7C-4F0A-AD30-9D55FB8EB8D5Q53266552-B192E3A7-1D26-46FF-A11E-B267B58B0F77Q57165717-2801DE49-B89E-4FAB-9585-3B2B32C72276Q57819275-022E081C-DA44-463A-AEB2-39A84194C213
P2860
Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@en
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@nl
type
label
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@en
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@nl
prefLabel
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@en
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@nl
P2860
P356
P1433
P1476
Regulation of matrix metallopr ...... pment of diabetic retinopathy.
@en
P2093
Qing Zhong
Renu A Kowluru
P2860
P304
P356
10.2337/DB12-1141
P407
P577
2013-02-19T00:00:00Z